title: Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI).
abstract: BACKGROUND
  Optimal adherence to antiretroviral therapy (ART) is necessary for people living with HIV/AIDS (PLHIV). There have been relatively few systematic analyses of factors that promote or inhibit adherence to antiretroviral therapy among PLHIV in Asia. This study assessed ART adherence and examined factors associated with suboptimal adherence in northern Viet Nam.
  
  
  METHODS
  Data from 615 PLHIV on ART in two urban and three rural outpatient clinics were collected by medical record extraction and from patient interviews using audio computer-assisted self-interview (ACASI).
  
  
  RESULTS
  The prevalence of suboptimal adherence was estimated to be 24.9% via a visual analogue scale (VAS) of past-month dose-missing and 29.1% using a modified Adult AIDS Clinical Trial Group scale for on-time dose-taking in the past 4 days. Factors significantly associated with the more conservative VAS score were: depression (p < 0.001), side-effect experiences (p < 0.001), heavy alcohol use (p = 0.001), chance health locus of control (p = 0.003), low perceived quality of information from care providers (p = 0.04) and low social connectedness (p = 0.03). Illicit drug use alone was not significantly associated with suboptimal adherence, but interacted with heavy alcohol use to reduce adherence (p < 0.001).
  
  
  CONCLUSIONS
  This is the largest survey of ART adherence yet reported from Asia and the first in a developing country to use the ACASI method in this context. The evidence strongly indicates that ART services in Viet Nam should include screening and treatment for depression, linkage with alcohol and/or drug dependence treatment, and counselling to address the belief that chance or luck determines health outcomes.
authors.forename: Hoa M
authors.initials: HM
authors.lastname: Do
authors.forename: Michael P
authors.initials: MP
authors.lastname: Dunne
authors.forename: Masaya
authors.initials: M
authors.lastname: Kato
authors.forename: Cuong V
authors.initials: CV
authors.lastname: Pham
authors.forename: Kinh V
authors.initials: KV
authors.lastname: Nguyen
mesh_terms: D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001296:Audiovisual Aids; D003430:Cross-Sectional Studies; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008875:Middle Aged; D057566:Self Report; D019966:Substance-Related Disorders / Q000150:complications / Q000188:drug therapy*; D014744:Vietnam; D016903:Drug Monitoring
chemical_list: D019380:Anti-HIV Agents
references.citation: AIDS Care. 2005 Oct;17(7):853-62
references.pmid: 16120502
references.citation: Antivir Ther. 2008;13(5):697-703
references.pmid: 18771053
references.citation: Trop Med Int Health. 2010 Mar;15(3):362-81
references.pmid: 20409291
references.citation: HIV Med. 2010 Jan;11(1):46-53
references.pmid: 19601996
references.citation: AIDS. 2007 Dec;21 Suppl 8:S149-55
references.pmid: 18172384
references.citation: Am J Psychiatry. 2002 Oct;159(10):1752-9
references.pmid: 12359683
references.citation: PLoS Med. 2009 Oct;6(10):e1000159
references.pmid: 19806179
references.citation: Antivir Ther. 2007;12(7):1067-74
references.pmid: 18018765
references.citation: AIDS Behav. 2010 Jun;14(3):580-9
references.pmid: 19771504
references.citation: J Adolesc Health. 2006 Jun;38(6):740-7
references.pmid: 16730604
references.citation: Science. 1998 May 8;280(5365):867-73
references.pmid: 9572724
references.citation: J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S41-7
references.pmid: 17091022
references.citation: J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):180-202
references.pmid: 19668086
references.citation: AIDS Behav. 2006 May;10(3):227-45
references.pmid: 16783535
references.citation: AIDS. 2006 Aug 1;20(12):1571-82
references.pmid: 16868437
references.citation: Clin Infect Dis. 2000 Jun;30 Suppl 2:S171-6
references.pmid: 10860902
references.citation: J Clin Pharm Ther. 2006 Dec;31(6):605-16
references.pmid: 17176366
references.citation: J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):154-9
references.pmid: 16394846
references.citation: Clin Nurs Res. 2005 Aug;14(3):273-93
references.pmid: 15995155
references.citation: Int J STD AIDS. 2009 Jun;20(6):418-22
references.pmid: 19451329
references.citation: AIDS Care. 2000 Jun;12(3):255-66
references.pmid: 10928201
references.citation: J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S48-53
references.pmid: 17133204
references.citation: PLoS Med. 2009 Jan 27;6(1):e11
references.pmid: 19175285
references.citation: AIDS. 2002 Jan 25;16(2):269-77
references.pmid: 11807312
references.citation: Health Psychol. 2006 May;25(3):355-363
references.pmid: 16719607
references.citation: J Consult Clin Psychol. 1976 Aug;44(4):580-5
references.pmid: 939841
references.citation: AIDS. 2008 Jul 11;22(11):1247-56
references.pmid: 18580603
references.citation: Int J Psychiatry Med. 1990;20(3):259-77
references.pmid: 2265888
references.citation: PLoS Med. 2006 Nov;3(11):e438
references.pmid: 17121449
references.citation: AIDS. 2000 Mar 10;14(4):357-66
references.pmid: 10770537